
Aspiel Syringes Private Limited
About Aspiel Syringes Private Limited
Data last updated:
Aspiel Syringes Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 11 January 2023.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33302GJ2023PTC138314. Its GSTIN is 24AAYCA2192G1ZF (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prujal Rajendra Parekh and Paridhi Vinod Khandhar.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sur – 31 2 Ndfloor L.M.College Of Pharmacy Opp. Ahmedabad Ni Gufa Navrangpura, Gujarat, India – 380009.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.68 Lakh, a growth of 121% compared to the previous year. For the same year it recorded a net loss of ₹58,463 (net margin -1.6%) and EBITDA of ₹5.69 Lakh (EBITDA margin 16%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aspiel Syringes Private Limited's registered office is in Ahmedabad, Gujarat.
- Registered AddressSur – 31 2 Ndfloor L.M.College Of Pharmacy Opp. Ahmedabad Ni Gufa Navrangpura, Gujarat, India – 380009
- IndustryHealthcare, Medical Consumables & Supplies
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aspiel Syringes Private Limited
FY 2025 filings availableAspiel Syringes Private Limited reported revenue of ₹35.68 Lakh (up 121% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 121% in the latest year. EBITDA rose 971% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹5.69 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹58,463 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 16% | ||
| Net Profit Margin | -1.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Aspiel Syringes Private Limited, buy the company report.
Board of directors of Aspiel Syringes Private Limited
Aspiel Syringes has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prujal Rajendra Parekh | Director | 11 Jan 2023 | 3 Years 9 Months | Current |
| Paridhi Vinod Khandhar | Director | 11 Jan 2023 | 3 Years 9 Months | Current |
Peer comparison
Aspiel Syringes Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Medical Consumables), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medlis Healthcare Private Limited | ₹39.18 Lakh (FY 2025) | 0.0% | Delhi, India | |||
| Experity Sushil Nurses Staffing Private Limited | ₹38.54 Lakh (FY 2025) | 3.0% | Thane, Maharashtra, India | |||
| Y V R Medivision Private Limited | ₹38.05 Lakh (FY 2025) | -29.0% | Hyderabad, Telangana, India | |||
| Adana Biotech Private Limited | ₹37.24 Lakh (FY 2025) | 17.0% | New Delhi, Delhi, India | |||
| Arka Multitech Private Limited | ₹35.98 Lakh (FY 2025) | -49.0% | Chennai, Tamil Nadu, India | |||
| Aspiel Syringes Private Limitedthis company | ₹35.68 Lakh (FY 2025) | -₹58,463 | -1.6% | 121.0% | Ahmedabad, Gujarat, India | |
| Acoma International Private Limited | ₹35.12 Lakh (FY 2025) | -9.0% | Surat, Gujarat, India | |||
| Saral Design Solutions Private Limited | ₹34.09 Lakh (FY 2025) | -92.0% | Navi Mumbai, Maharashtra, India | |||
| Vibles Medicare Private Limited | ₹34.05 Lakh (FY 2024) | -21.0% | Rajouri Garden, Delhi, India | |||
| Khanal Industries Private Limited | ₹33.94 Lakh (FY 2025) | -34.0% | Bengaluru, Karnataka, India | |||
| S P Prints Private Limited | ₹33 Lakh (FY 2023) | 11.0% | Delhi, India |
To see the full peer comparison of Aspiel Syringes Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aspiel Syringes Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aspiel Syringes Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aspiel Syringes has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAYCA2192G1ZF | Gujarat | Active | 29 Sep 2023 |
To see the full GST registrations and return filing status of Aspiel Syringes Private Limited, buy the company report.
Recent activity
Aspiel Syringes Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Paridhi Vinod Khandhar was appointed as Director on 11 Jan 2023.
Frequently asked questions
Aspiel Syringes is an active private limited company based in Ahmedabad, Gujarat, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 11 January 2023 (3+ years old) and is registered under CIN U33302GJ2023PTC138314.
Aspiel Syringes has 2 current directors:
- Prujal Rajendra Parekh - Director
- Paridhi Vinod Khandhar - Director
The latest financial statements of Aspiel Syringes on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Aspiel Syringes is 24AAYCA2192G1ZF, registered in Gujarat.
The CIN (Corporate Identification Number) of Aspiel Syringes is U33302GJ2023PTC138314. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aspiel Syringes was incorporated on 11 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Aspiel Syringes by revenue are Medlis Healthcare Private Limited, Experity Sushil Nurses Staffing Private Limited, Y V R Medivision Private Limited, Adana Biotech Private Limited, Arka Multitech Private Limited and 5 more, all in the Healthcare industry (Medical Consumables).
Paridhi Vinod Khandhar was appointed as Director on 11 Jan 2023. Prujal Rajendra Parekh was appointed as Director on 11 Jan 2023.
The registered office of Aspiel Syringes is at Sur – 31 2 Ndfloor L.M.College Of Pharmacy Opp. Ahmedabad Ni Gufa Navrangpura, Gujarat, India – 380009.
Aspiel Syringes operates in the healthcare industry, in the medical consumables and supplies segment.
The compliance status of Aspiel Syringes is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.

